|
|
|||
|
||||
OverviewCardiovascular diseases (CVD) are a group of diseases that affect the heart and its functions. Biomarkers or biological markers are measurable and quantifiable biological indicators of health and some diseases. They play a crucial role in the implication of assessments related to health and physiology that cover a plethora of parameters, including disease progression and risk, psychiatric disorders, disease diagnosis, and metabolic processes. A CVD biomarker is used to improve the optimal clinical management and treatment of the patient. Various cardiac enzymes act as cardiac biomarkers, which comprise myoglobin, troponin and creatine kinase. The heart releases cardiac biomarkers into the bloodstream when it experiences damage or stress due to lack of oxygen. These biomarkers assist in determining if symptoms are due to a myocardial infarction, angina, heart failure or some other health problems. Enzyme marker test is utilized to measure specific biomarkers in the blood. This book elucidates the role of cardiovascular biomarkers in pathophysiology and disease management. It consists of contributions made by international experts. This book will serve as a valuable source of reference for scholars and researchers. Full Product DetailsAuthor: John FreemanPublisher: American Medical Publishers Imprint: American Medical Publishers Dimensions: Width: 21.60cm , Height: 1.40cm , Length: 27.90cm Weight: 0.853kg ISBN: 9781639279616ISBN 10: 163927961 Pages: 242 Publication Date: 26 September 2023 Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Available To Order We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||